All these factors, including the number of exfoliating cells, inflammatory cell infiltration, the expression of COX-2 mRNA in cancer tissue, and the size and location of the tumour, may contribute to the expression of faecal COX-2 mRNA in CRC. This evidence concerns the gene PTGS2 and colorectal carcinoma.